The current stock price of NH is 1.35 USD. In the past month the price decreased by -10.6%. In the past year, price decreased by -82.91%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 30.92 | 39.34B | ||
| DOCS | DOXIMITY INC-CLASS A | 28.35 | 8.75B | ||
| WAY | WAYSTAR HOLDING CORP | 25.13 | 6.44B | ||
| HTFL | HEARTFLOW INC | N/A | 2.77B | ||
| CERT | CERTARA INC | 18.98 | 1.51B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.34B | ||
| SDGR | SCHRODINGER INC | N/A | 1.38B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 641.88 | 1.09B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| PHR | PHREESIA INC | N/A | 1.05B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.14 | 967.38M | ||
| HSTM | HEALTHSTREAM INC | 33.46 | 674.99M |
NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. The company is headquartered in Morrisville, North Carolina and currently employs 364 full-time employees. The company went IPO on 2016-06-02. The firm is engaged in offering ways to move, interpret, and visualize complex and highly sensitive information to its customers in the healthcare, life sciences, logistics, telecommunications, and other industries to automate, understand, and act on data while keeping it secure and scalable. The Company’s products include Eviti Connect and Eviti Advisor, NaviNet, NaviNet Open, NaviNet AllPayer, OpenNMS, and Quadris. Its product portfolio comprises the technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet) and data solutions that include multi-data analysis, reporting, and professional service offerings (Quadris). In addition, The OpenNMS Group, Inc. (OpenNMS), a Company’s subsidiary, helps businesses monitor and manage network health and performance.
NANTHEALTH INC
3000 Rdu Center Drive, Suite 200
Morrisville NORTH CAROLINA 90232 US
CEO: Patrick Soon-Shiong
Employees: 364
Phone: 18559496288.0
NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. The company is headquartered in Morrisville, North Carolina and currently employs 364 full-time employees. The company went IPO on 2016-06-02. The firm is engaged in offering ways to move, interpret, and visualize complex and highly sensitive information to its customers in the healthcare, life sciences, logistics, telecommunications, and other industries to automate, understand, and act on data while keeping it secure and scalable. The Company’s products include Eviti Connect and Eviti Advisor, NaviNet, NaviNet Open, NaviNet AllPayer, OpenNMS, and Quadris. Its product portfolio comprises the technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet) and data solutions that include multi-data analysis, reporting, and professional service offerings (Quadris). In addition, The OpenNMS Group, Inc. (OpenNMS), a Company’s subsidiary, helps businesses monitor and manage network health and performance.
The current stock price of NH is 1.35 USD. The price decreased by -46.64% in the last trading session.
NH does not pay a dividend.
NH has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
You can find the ownership structure of NANTHEALTH INC (NH) on the Ownership tab.
ChartMill assigns a technical rating of 1 / 10 to NH. When comparing the yearly performance of all stocks, NH is a bad performer in the overall market: 96.89% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to NH. NH may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months NH reported a non-GAAP Earnings per Share(EPS) of -8.32. The EPS decreased by -240.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
9 analysts have analysed NH and the average price target is 61.2 USD. This implies a price increase of 4433.33% is expected in the next year compared to the current price of 1.35.